Troxacitabine and imatinib mesylate combination therapy of chronic myeloid leukaemia: Preclinical evaluation

Nada Orsolic, Francis J. Giles, Henriette Gourdeau, Mirna Golemovic, Miloslav Beran, Jorge Cortes, Emu J. Freireich, Hagop Kantarjian, Srdan Verstovsek*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

7 Scopus citations

Fingerprint

Dive into the research topics of 'Troxacitabine and imatinib mesylate combination therapy of chronic myeloid leukaemia: Preclinical evaluation'. Together they form a unique fingerprint.

INIS

Pharmacology, Toxicology and Pharmaceutical Science